Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2012 1
2013 4
2014 3
2015 5
2016 4
2017 8
2018 3
2019 5
2020 5
2021 3
2022 7
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Emerging heterocycles as bioactive compounds.
Li Petri G, Holl R, Spanò V, Barreca M, Sardo I, Raimondi MV. Li Petri G, et al. Among authors: spano v. Front Chem. 2023 Apr 26;11:1202192. doi: 10.3389/fchem.2023.1202192. eCollection 2023. Front Chem. 2023. PMID: 37179776 Free PMC article. No abstract available.
Identification of pyrrolo[3',4':3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas.
Barreca M, Spanò V, Rocca R, Bivacqua R, Gualtieri G, Raimondi MV, Gaudio E, Bortolozzi R, Manfreda L, Bai R, Montalbano A, Alcaro S, Hamel E, Bertoni F, Viola G, Barraja P. Barreca M, et al. Among authors: spano v. Eur J Med Chem. 2023 Jun 5;254:115372. doi: 10.1016/j.ejmech.2023.115372. Epub 2023 Apr 12. Eur J Med Chem. 2023. PMID: 37068384
New tricyclic systems as photosensitizers towards triple negative breast cancer cells.
Barreca M, Ingarra AM, Raimondi MV, Spanò V, Piccionello AP, De Franco M, Menilli L, Gandin V, Miolo G, Barraja P, Montalbano A. Barreca M, et al. Among authors: spano v. Arch Pharm Res. 2022 Nov;45(11):806-821. doi: 10.1007/s12272-022-01414-1. Epub 2022 Nov 18. Arch Pharm Res. 2022. PMID: 36399284 Free PMC article.
Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomas.
Barreca M, Spanò V, Rocca R, Bivacqua R, Abel AC, Maruca A, Montalbano A, Raimondi MV, Tarantelli C, Gaudio E, Cascione L, Rinaldi A, Bai R, Steinmetz MO, Prota AE, Alcaro S, Hamel E, Bertoni F, Barraja P. Barreca M, et al. Among authors: spano v. Eur J Med Chem. 2022 Dec 5;243:114744. doi: 10.1016/j.ejmech.2022.114744. Epub 2022 Sep 8. Eur J Med Chem. 2022. PMID: 36242921
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma.
Grillone K, Riillo C, Rocca R, Ascrizzi S, Spanò V, Scionti F, Polerà N, Maruca A, Barreca M, Juli G, Arbitrio M, Di Martino MT, Caracciolo D, Tagliaferri P, Alcaro S, Montalbano A, Barraja P, Tassone P. Grillone K, et al. Among authors: spano v. Int J Mol Sci. 2022 Sep 6;23(18):10222. doi: 10.3390/ijms231810222. Int J Mol Sci. 2022. PMID: 36142133 Free PMC article.
51 results